75 results
Page 2 of 4
6-K
EX-1.1
9gxc3jetwtpv tp
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
424B5
aocucct4bd iripx
10 Feb 21
Prospectus supplement for primary offering
5:22pm
424B5
r2crka6sprn9o4c9
9 Feb 21
Prospectus supplement for primary offering
4:56pm
6-K
EX-10.1
0brpaalxa5583jddz o2
22 Oct 20
Report of Foreign Private Issuer
8:47am
424B5
4dgi2bls t9
22 Oct 20
Prospectus supplement for primary offering
8:45am
6-K
a5ry3lw4t1c0x5a0k
29 Jun 20
Report of Foreign Private Issuer
8:00am
6-K
EX-99.1
x2525txn5wqoswxzgkce
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
6-K
EX-99.2
e68jdp1sf6qo
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
6-K
3d7uz2d3er 4fv0md
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
6-K
EX-1.1
bw57o
5 Mar 20
Report of Foreign Private Issuer
8:16am
424B5
346 ysd4x06pq
3 Mar 20
Prospectus supplement for primary offering
5:13pm
6-K
EX-1.1
xeebmq1
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
424B5
94n anvim
26 Feb 20
Prospectus supplement for primary offering
8:23am